Johnson & Johnson News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

25.03.22	ViiV Healthcare : FDA Approves Label Update For Long-acting HIV Treatment Cabenuva (RTTNews)
15.03.22	Johnson & Johnson to Host Investor Conference Call on First-Quarter Results (PR Newswire)
09.03.22	Form 4 200406 (RSS)
01.03.22	Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease (PR Newswire)
25.02.22	J&J Bankruptcy Ploy Upheld By NJ Court (RTTNews)
25.02.22	Initial statement of beneficial ownership of securities (RSS)
15.02.22	Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors (PR Newswire)
15.02.22	Form 4 200406 (RSS)
09.02.22	Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference (PR Newswire)
08.02.22	J&J Stops Production Of Its COVID-19 Vaccine, Says NYT (RTTNews)
07.02.22	Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference (PR Newswire)
27.01.22	Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference (PR Newswire)
25.01.22	Johnson & Johnson Projects 2022 Adj. Operational EPS Growth Of 9.2% (RTTNews)
25.01.22	Johnson & Johnson Q4 Profit Increases, beats estimates (RTTNews)
25.01.22	Johnson & Johnson Reports Q4 and Full-Year 2021 Results (PR Newswire)
19.01.22	Form 4 200406 (RSS)
13.01.22	Initial statement of beneficial ownership of securities (RSS)
07.01.22	Johnson & Johnson Vaccine Protects Up To Six Months Against COVID-19 Breakthrough Infections (RTTNews)
06.01.22	Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States (PR Newswire)
04.01.22	Johnson & Johnson Announces Quarterly Dividend for First Quarter 2022 (PR Newswire)
30.12.21	J&J's COVID-19 Booster Shot 85% Effective Against Hospitalization, In South Africa Phase 3 Study (RTTNews)
30.12.21	Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant (PR Newswire)
23.12.21	Top 10 Blockbuster Drugs In 2021 (RTTNews)
17.12.21	CDC Recommends Pfizer, Moderna COVID-19 Vaccines Over J&J Due To Rare Blood Clots (RTTNews)
15.12.21	Johnson & Johnson Receives Positive CHMP Opinion For Booster Shot Of COVID-19 Vaccine (RTTNews)
15.12.21	Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine (PR Newswire)
15.12.21	EMA Recommends Covid-19 Vaccine Janssen Booster Shot For Adults (RTTNews)
13.12.21	J&J Talcum Powder Woes Continue As SC Declines To Hear The Company (RTTNews)
10.12.21	Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results (PR Newswire)
09.12.21	World Health Organization Strategic Advisory Group of Experts (SAGE) Interim Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster (PR Newswire)
09.12.21	Johnson & Johnson Appoints Senior Leaders to Executive Committee (PR Newswire)
09.12.21	Form 4 200406 (RSS)
06.12.21	Johnson & Johnson Says Its COVID-19 Booster Shows Increase In Antibody And T-cell Responses (RTTNews)
05.12.21	Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses (PR Newswire)
04.12.21	Janssen to Showcase Progress on Respiratory Syncytial Virus (RSV) Vaccine Candidate at ESWI 2021 (PR Newswire)
02.12.21	Amgen : FDA Approves Kyprolis Combination Regimen For Multiple Myeloma Treatment (RTTNews)
30.11.21	CDC Strengthens Booster Recommendation For All Adults Due To Omicron Variant Concerns (RTTNews)
29.11.21	Vaccine Makers Investigate New Covid Variant, To Adapt Shots If Needed (RTTNews)
24.11.21	Health Canada Approves Johnson & Johnson COVID-19 Vaccine - Quick Facts (RTTNews)
12.11.21	J&J Plans To Form Separate Consumer Health Company (RTTNews)
12.11.21	Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business (PR Newswire)
10.11.21	Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World's Most Vulnerable People through Novel Humanitarian Buffer (PR Newswire)
09.11.21	Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards (PR Newswire)
22.10.21	Walgreens Offers Moderna And Johnson & Johnson COVID-19 Vaccine Booster Shots In U.S. (RTTNews)
22.10.21	CDC Panel Backs Johnson & Johnson COVID-19 Booster Shot (RTTNews)
22.10.21	U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines (PR Newswire)
21.10.21	Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2021 (PR Newswire)
21.10.21	FDA Authorizes Johnson & Johnson And Moderna Booster Shots (RTTNews)
21.10.21	Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA (PR Newswire)
19.10.21	Will FDA Allow 'mix And Match' Of Covid Booster Shots? (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

21.11.24		Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone
21.11.24		Börse Europa in Grün: STOXX 50 zeigt sich zum Ende des Donnerstagshandels fester
21.11.24		Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX
21.11.24		Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen
21.11.24		Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus
21.11.24		Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone
21.11.24		SLI aktuell: Anleger lassen SLI letztendlich steigen

21.11.24

Aufschläge in New York: Dow Jones letztendlich in der Gewinnzone

21.11.24

Börse Europa in Grün: STOXX 50 zeigt sich zum Ende des Donnerstagshandels fester

21.11.24

Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX

21.11.24

Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen

21.11.24

Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus

21.11.24

Börse Europa: Euro STOXX 50 letztendlich in der Gewinnzone